Tarsus Pharmaceuticals Inc (TARS)
49.29
+2.79
(+6.00%)
USD |
NASDAQ |
Nov 14, 10:21
Tarsus Pharmaceuticals Market Cap: 1.875B for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 1.769B |
| November 12, 2024 | 1.810B |
| November 11, 2024 | 1.867B |
| November 08, 2024 | 1.880B |
| November 07, 2024 | 1.780B |
| November 06, 2024 | 1.780B |
| November 05, 2024 | 1.737B |
| November 04, 2024 | 1.758B |
| November 01, 2024 | 1.799B |
| October 31, 2024 | 1.692B |
| October 30, 2024 | 1.702B |
| October 29, 2024 | 1.669B |
| October 28, 2024 | 1.509B |
| October 25, 2024 | 1.499B |
| October 24, 2024 | 1.479B |
| October 23, 2024 | 1.484B |
| October 22, 2024 | 1.446B |
| October 21, 2024 | 1.387B |
| October 18, 2024 | 1.393B |
| October 17, 2024 | 1.410B |
| October 16, 2024 | 1.430B |
| October 15, 2024 | 1.418B |
| October 14, 2024 | 1.388B |
| October 11, 2024 | 1.358B |
| October 10, 2024 | 1.350B |
| Date | Value |
|---|---|
| October 09, 2024 | 1.321B |
| October 08, 2024 | 1.293B |
| October 07, 2024 | 1.263B |
| October 04, 2024 | 1.289B |
| October 03, 2024 | 1.228B |
| October 02, 2024 | 1.246B |
| October 01, 2024 | 1.228B |
| September 30, 2024 | 1.251B |
| September 27, 2024 | 1.237B |
| September 26, 2024 | 1.261B |
| September 25, 2024 | 1.232B |
| September 24, 2024 | 1.257B |
| September 23, 2024 | 1.262B |
| September 20, 2024 | 1.313B |
| September 19, 2024 | 1.316B |
| September 18, 2024 | 1.238B |
| September 17, 2024 | 1.181B |
| September 16, 2024 | 1.213B |
| September 13, 2024 | 1.265B |
| September 12, 2024 | 1.206B |
| September 11, 2024 | 1.210B |
| September 10, 2024 | 1.196B |
| September 09, 2024 | 1.189B |
| September 06, 2024 | 1.164B |
| September 05, 2024 | 1.039B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
267.80M
Minimum
May 04 2022
1.880B
Maximum
Nov 08 2024
648.52M
Average
524.85M
Median
Sep 01 2021
Market Cap Benchmarks
| Amicus Therapeutics Inc | 3.060B |
| CEL-SCI Corp | 36.29M |
| AIM ImmunoTech Inc | 15.17M |
| IGC Pharma Inc | 27.46M |
| NovaBay Pharmaceuticals Inc | 3.518M |
Market Cap Related Metrics
| PS Ratio | 20.26 |
| PEG Ratio | -0.3398 |
| Price to Book Value | 7.434 |
| Price | 49.29 |
| Earnings Yield | -9.09% |
| PEGY Ratio | -0.3398 |